Publications Laurent MAUVIEUX avant 2018

Ojeda-Uribe, M., Jeandidier, E., Cornillet-Lefebvre, P., Bechec, A. L., & Mauvieux, L. (2017). Molecular profiling by whole-exome-sequencing of two patients with t-AML post combined therapy of acute promyelocytic leukemia. Experimental Hematology, 53, S74.
Ittel, A., Gervais, C., Galoisy, A. C., M’Kacher, R., Mauvieux, L., & Fornecker, L. M. (2017). Triradial and quadriradial chromosomes detected in a case of B-cell prolymphocytic leukaemia. British Journal of Haematology, 179(5), 704.
Delabranche, X., Stiel, L., Severac, F., Galoisy, A.-C., Mauvieux, L., Zobairi, F., Lavigne, T., Toti, F., Anglès-Cano, E., Meziani, F., & Boisramé-Helms, J. (2017). Evidence of Netosis in Septic Shock-Induced Disseminated Intravascular Coagulation. Shock (Augusta, Ga.), 47(3), 313–317.
Stiel, L., Delabranche, X., Galoisy, A.-C., Severac, F., Toti, F., Mauvieux, L., Meziani, F., & Boisramé-Helms, J. (2016). Neutrophil Fluorescence: A New Indicator of Cell Activation During Septic Shock-Induced Disseminated Intravascular Coagulation. Critical Care Medicine, 44(11), e1132–e1136.
Mayeur-Rousse, C., Guy, J., Miguet, L., Bouyer, S., Geneviève, F., Robillard, N., Solly, F., Maar, A., Bené, M. C., Mauvieux, L., & GEIL (Groupe d’Etude Immunologique des Leucémies). (2016). CD180 expression in B-cell lymphomas: A multicenter GEIL study. Cytometry. Part B, Clinical Cytometry, 90(5), 462–466.
Apostolov, A., Litim-Mecheri, I., Oravecz, A., Goepp, M., Kirstetter, P., Marchal, P., Ittel, A., Mauvieux, L., Chan, S., & Kastner, P. (2016). Sumoylation Inhibits the Growth Suppressive Properties of Ikaros. PloS One, 11(6), e0157767.
Ittel, A., Hélias, C., Wissler, M. P., Toussaint, E., Miguet, L., Chenard, M. P., Monier, L., Gervais, C., & Mauvieux, L. (2015). Four genetic lymphoma-specific events (MYC, BCL2, BCL6 and CCND1) identified in a high grade B lymphoma case. Blood Cancer Journal, 5, e374.
Monier, L., & Mauvieux, L. (2015). Cystine crystals in bone marrow aspirate. Blood, 126(12), 1515.
Reix, N., Agin, A., Bahram, S., Dali-Youcef, N., Grucker, D., Jaulhac, B., Lepiller, Q., Lessinger, J.-M., Mauvieux, L., Monier, L., Schramm, F., Stoll-Keller, F., Vallat, L., Ludes, B., Candolfi, E., & Filisetti, D. (2015). [Clinical laboratory medicine: continuous amelioration with a book of objectives and satisfaction survey]. Annales De Biologie Clinique, 73(3), 359–368.
Alhosin, M., León-González, A. J., Dandache, I., Lelay, A., Rashid, S. K., Kevers, C., Pincemail, J., Fornecker, L.-M., Mauvieux, L., Herbrecht, R., & Schini-Kerth, V. B. (2015). Bilberry extract (Antho 50) selectively induces redox-sensitive caspase 3-related apoptosis in chronic lymphocytic leukemia cells by targeting the Bcl-2/Bad pathway. Scientific Reports, 5, 8996.
Duval, C., Boucher, S., Moulin, J.-C., Gourieux, B., Mauvieux, L., Leveque, D., & Herbrecht, R. (2014). Fatal stimulation of acute myeloid leukemia blasts by pegfilgrastim. Anticancer Research, 34(11), 6747–6748.
Ittel, A., Jeandidier, E., Helias, C., Perrusson, N., Humbrecht, C., Lioure, B., Mazurier, I., Mayeur-Rousse, C., Lavaux, A., Thiebault, S., Lerintiu, F., Gervais, C., & Mauvieux, L. (2013). First description of the t(10;11)(q22;q23)/MLL-TET1 translocation in a T-cell lymphoblastic lymphoma, with subsequent lineage switch to acute myelomonocytic myeloid leukemia. Haematologica, 98(12), e166-168.
Miguet, L., Lennon, S., Baseggio, L., Traverse-Glehen, A., Berger, F., Perrusson, N., Chenard, M.-P., Galoisy, A.-C., Eischen, A., Mayeur-Rousse, C., Maar, A., Fornecker, L., Herbrecht, R., Felman, P., Van Dorsselaer, A., Carapito, C., Cianférani, S., & Mauvieux, L. (2013). Cell-surface expression of the TLR homolog CD180 in circulating cells from splenic and nodal marginal zone lymphomas. Leukemia, 27(8), 1748–1750.
Gervais, C., Dano, L., Perrusson, N., Hélias, C., Jeandidier, E., Galoisy, A.-C., Ittel, A., Herbrecht, R., Bilger, K., & Mauvieux, L. (2013). A translocation t(2;8)(q12;p11) fuses FGFR1 to a novel partner gene, RANBP2/NUP358, in a myeloproliferative/myelodysplastic neoplasm. Leukemia, 27(5), 1186–1188.
Dupuis, A., Gaub, M. P., Legrain, M., Drenou, B., Mauvieux, L., Lutz, P., Herbrecht, R., Chan, S., & Kastner, P. (2013). Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations. Leukemia, 27(2), 503–507.
Ojeda-Uribe, M., Schneider, A., Luquet, I., Berceanu, A., Cornillet-Lefebvre, P., Jeandidier, E., Lioure, B., Ades, L., Mauvieux, L., & Himberlin, C. (2012). Therapy-related acute myeloid leukemia (t-AML) with poor-risk cytogenetics in two patients with persistent molecular complete remission of acute promyelocytic leukemia. European Journal of Haematology, 89(3), 267–272.
Jeandidier, E., Gervais, C., Radford-Weiss, I., Zink, E., Gangneux, C., Eischen, A., Galoisy, A. C., Helias, C., Dano, L., Cammarata, O., Jung, G., Harzallah, I., Guérin, E., Martzolff, L., Drénou, B., Lioure, B., Tancrédi, C., Rimelen, V., & Mauvieux, L. (2012). A cytogenetic study of 397 consecutive acute myeloid leukemia cases identified three with a t(7;21) associated with 5q abnormalities and exhibiting similar clinical and biological features, suggesting a new, rare acute myeloid leukemia entity. Cancer Genetics, 205(7–8), 365–372.
Samyn, B., Grunebaum, L., Amiral, J., Ammouche, C., Lounis, K., Eicher, E., Mauvieux, L., & Desprez, D. (2012). [Post-varicella cerebral thrombophlebitis with anti-protein S: report of a pediatric case]. Annales De Biologie Clinique, 70(1), 99–103.
Desprez, D., Desprez, P., Tardy, B., Amiral, J., Droulle, C., Ducassou, S., Mauvieux, L., & Grunebaum, L. (2010). [Anti-PF4 antibodies and thrombophlebitis in a child with cerebral venous thrombosis]. Annales De Biologie Clinique, 68(6), 725–728.
Miguet, L., Béchade, G., Fornecker, L., Zink, E., Felden, C., Gervais, C., Herbrecht, R., Van Dorsselaer, A., van Dorsselaer, A., Mauvieux, L., & Sanglier-Cianferani, S. (2009). Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis. Journal of Proteome Research, 8(7), 3346–3354.
Struski, S., Gervais, C., Helias, C., Herbrecht, R., Audhuy, B., & Mauvieux, L. (2009). Stimulation of B-cell lymphoproliferations with CpG-oligonucleotide DSP30 plus IL-2 is more effective than with TPA to detect clonal abnormalities. Leukemia, 23(3), 617–619.
Weingertner, A. S., Wilt, M., Atallah, I., Fohrer, C., Mauvieux, L., & Rodier, J.-F. (2009). Myeloid Sarcoma of the Uterine Cervix as Presentation of Acute Myeloid Leukaemia after Treatment with Low-Dose Radioiodine for Thyroid Cancer: A Case Report and Review of the Literature. Case Reports in Oncology, 2(1), 1–6.
Struski, S., Mauvieux, L., Gervais, C., Hélias, C., Liu, K. L., & Lessard, M. (2008). ETV6/GOT1 fusion in a case of t(10;12)(q24;p13)-positive myelodysplastic syndrome. Haematologica, 93(3), 467–468.
Hélias, C., Struski, S., Gervais, C., Leymarie, V., Mauvieux, L., Herbrecht, R., & Lessard, M. (2008). Polycythemia vera transforming to acute myeloid leukemia and complex abnormalities including 9p homogeneously staining region with amplification of MLLT3, JMJD2C, JAK2, and SMARCA2. Cancer Genetics and Cytogenetics, 180(1), 51–55.
Struski, S., Leymarie, V., Helias, C., Falkenrodt, A., Fohrer, C., Audhuy, B., Lioure, B., Moskovtchenko, P., Mazurier, I., Galoisy, A.-C., Gervais, C., Mauvieux, L., Herbrecht, R., Bergerat, J.-P., & Lessard, M. (2007). [A cytological, immunophenotypical and cytogenetical study of 136 consecutive cases of B-cell chronic lymphoid hemopathies]. Pathologie-Biologie, 55(1), 59–72.
Cauwelier, B., Cavé, H., Gervais, C., Lessard, M., Barin, C., Perot, C., Van den Akker, J., Mugneret, F., Charrin, C., Pagès, M. P., Grégoire, M.-J., Jonveaux, P., Lafage-Pochitaloff, M., Mozzicconacci, M. J., Terré, C., Luquet, I., Cornillet-Lefebvre, P., Laurence, B., Plessis, G., … Speleman, F. (2007). Clinical, cytogenetic and molecular characteristics of 14 T-ALL patients carrying the TCRbeta-HOXA rearrangement: a study of the Groupe Francophone de Cytogénétique Hématologique. Leukemia, 21(1), 121–128.
Miguet, L., Sanglier, S., Schaeffer, C., Potier, N., Mauvieux, L., & Van Dorsselaer, A. (2007). Microparticles : A New Tool for Plasma Membrane Sub-cellular Proteomic. In E. Bertrand & M. Faupel (Eds.), Subcellular Proteomics: From Cell Deconstruction to System Reconstruction (pp. 21–34). Springer Netherlands.
Miguet, L., Sanglier, S., Schaeffer, C., Potier, N., Mauvieux, L., & Van Dorsselaer, A. (2007). Microparticles: a new tool for plasma membrane sub-cellular proteomic. Sub-Cellular Biochemistry, 43, 21–34.
Miguet, L., Bogumil, R., Decloquement, P., Herbrecht, R., Potier, N., Mauvieux, L., & Van Dorsselaer, A. (2006). Discovery and identification of potential biomarkers in a prospective study of chronic lymphoid malignancies using SELDI-TOF-MS. Journal of Proteome Research, 5(9), 2258–2269.
Nadal, N., Flandrin, P., Cornillon, J., Delabesse, E., Mauvieux, L., Olaru, D., Morel, S., & Campos, L. (2006). Successful treatment with imatinib mesylate in a case of chronic myeloproliferative disorder with a t(5;12)(q33;p13.1) without eosinophilia. Cancer Genetics and Cytogenetics, 169(2), 174–175.
Miguet, L., Pacaud, K., Felden, C., Hugel, B., Martinez, M. C., Freyssinet, J.-M., Herbrecht, R., Potier, N., van Dorsselaer, A., & Mauvieux, L. (2006). Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization. Proteomics, 6(1), 153–171.
Gervais, C., Mauvieux, L., Perrusson, N., Hélias, C., Struski, S., Leymarie, V., Lioure, B., & Lessard, M. (2005). A new translocation t(9;11)(q34;p15) fuses NUP98 to a novel homeobox partner gene, PRRX2, in a therapy-related acute myeloid leukemia. Leukemia, 19(1), 145–148.
Mauvieux, L., Helias, C., Perrusson, N., Lioure, B., Sorel, N., Brizard, F., & Lessard, M. (2004). ETV6 (TEL) gene amplification in a myelodysplastic syndrome with excess of blasts. Leukemia, 18(8), 1436–1438.
Cavé, H., Suciu, S., Preudhomme, C., Poppe, B., Robert, A., Uyttebroeck, A., Malet, M., Boutard, P., Benoit, Y., Mauvieux, L., Lutz, P., Méchinaud, F., Grardel, N., Mazingue, F., Dupont, M., Margueritte, G., Pages, M.-P., Bertrand, Y., Plouvier, E., … EORTC-CLG. (2004). Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951. Blood, 103(2), 442–450.
Berger, R., Dastugue, N., Busson, M., Van Den Akker, J., Pérot, C., Ballerini, P., Hagemeijer, A., Michaux, L., Charrin, C., Pages, M. P., Mugneret, F., Andrieux, J., Talmant, P., Hélias, C., Mauvieux, L., Lafage-Pochitaloff, M., Mozziconacci, M.-J., Cornillet-Lefebvre, P., Radford, I., … Groupe Français de Cytogénétique Hématologique (GFCH). (2003). t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH). Leukemia, 17(9), 1851–1857.
Mauvieux, L., Villey, I., & de Villartay, J.-P. (2003). TEA regulates local TCR-Jalpha accessibility through histone acetylation. European Journal of Immunology, 33(8), 2216–2222.
Mauvieux, L., Leymarie, V., Helias, C., Perrusson, N., Falkenrodt, A., Lioure, B., Lutz, P., & Lessard, M. (2002). High incidence of Hox11L2 expression in children with T-ALL. Leukemia, 16(12), 2417–2422.
Mauvieux, L., Villey, I., & de Villartay, J. P. (2001). T early alpha (TEA) regulates initial TCRVAJA rearrangements and leads to TCRJA coincidence. European Journal of Immunology, 31(7), 2080–2086.<2080::AID-IMMU2080>3.0.CO;2-H
Patey-Mariaud De Serre, N., Cellier, C., Jabri, B., Delabesse, E., Verkarre, V., Roche, B., Lavergne, A., Brière, J., Mauvieux, L., Leborgne, M., Barbier, J. P., Modigliani, R., Matuchansky, C., MacIntyre, E., Cerf-Bensussan, N., & Brousse, N. (2000). Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method. Histopathology, 37(1), 70–77.
Mauvieux, L., Delabesse, E., Bourquelot, P., Radford-Weiss, I., Bennaceur, A., Flandrin, G., Valensi, F., & MacIntyre, E. A. (1999). NG2 expression in MLL rearranged acute myeloid leukaemia is restricted to monoblastic cases. British Journal of Haematology, 107(3), 674–676.
Troussard, X., Mauvieux, L., Radford-Weiss, I., Rack, K., Valensi, F., Garand, R., Vekemans, M., Flandrin, G., & Macintyre, E. A. (1998). Genetic analysis of splenic lymphoma with villous lymphocytes: a Groupe Français d’Hématologie Cellulaire (GFHC) study. British Journal of Haematology, 101(4), 712–721.
Cellier, C., Patey, N., Mauvieux, L., Jabri, B., Delabesse, E., Cervoni, J. P., Burtin, M. L., Guy-Grand, D., Bouhnik, Y., Modigliani, R., Barbier, J. P., Macintyre, E., Brousse, N., & Cerf-Bensussan, N. (1998). Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology, 114(3), 471–481.
Mauvieux, L., Canioni, D., Hermine, O., Valensi, F., Radford-Weiss, I., Azagury, M., Magen, M., Flandrin, G., Brousse, N., Varet, B., & Macintyre, E. A. (1998). Quantitative RNA slot-blot analysis of CCND1/cyclin D1 expression in suspected mantle cell lymphoma. Leukemia, 12(1), 78–85.
Mauvieux, L., & Macintyre, E. (1997). [Molecular anomalies in malignant hemopathies]. Presse Medicale (Paris, France: 1983), 26(21), 1005–1007.
Mauvieux, L., Delabesse, E., & Macintyre, E. (1997). Molecular genetics of acute leukemias. Reviews in Clinical and Experimental Hematology, 2, 3–26.
Mauvieux, L., & Macintyre, E. A. (1996). Practical role of molecular diagnostics in non-Hodgkin’s lymphomas. Baillière’s Clinical Haematology, 9(4), 653–667.
Raynaud, S., Mauvieux, L., Cayuela, J. M., Bastard, C., Bilhou-Nabera, C., Debuire, B., Bories, D., Boucheix, C., Charrin, C., Fière, D., & Gabert, J. (1996). TEL/AML1 fusion gene is a rare event in adult acute lymphoblastic leukemia. Leukemia, 10(9), 1529–1530.
Parès, Y., Martinet, R., Cuper, J., Giraud, J., Loko, H., Gagnaire, L., Mauvieux, L., & Preira, M. (1965). [Use of inexpensive culture media for gold solubilization by means of bacteria]. Annales De l’Institut Pasteur, 108(5), 674–681.